These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22919317)

  • 1. The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients.
    Lazzeri S; Orlandi P; Figus M; Fioravanti A; Cascio E; Di Desidero T; Agosta E; Canu B; Sartini MS; Danesi R; Nardi M; Bocci G
    ScientificWorldJournal; 2012; 2012():420190. PubMed ID: 22919317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
    Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
    Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF A (rs699947 and rs833061) and VEGFR2 (rs2071559) gene polymorphisms are not associated with AMD susceptibility in a Spanish population.
    Cruz-González F; Cieza-Borrella C; Cabrillo-Estévez L; Cañete-Campos C; Escudero-Domínguez F; González-Sarmiento R
    Curr Eye Res; 2013 Dec; 38(12):1274-7. PubMed ID: 23971975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
    Fang AM; Lee AY; Kulkarni M; Osborn MP; Brantley MA
    Mol Vis; 2009 Dec; 15():2710-9. PubMed ID: 20019880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
    García M; Álvarez L; Fernández Á; González-Iglesias H; Escribano J; Fernández-Vega B; Villota E; Fernández-Vega Cueto L; Fernández-Vega Á; Coca-Prados M
    Ophthalmic Genet; 2017; 38(5):451-458. PubMed ID: 28635422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.
    Lazzeri S; Orlandi P; Piaggi P; Sartini MS; Casini G; Guidi G; Figus M; Fioravanti A; Di Desidero T; Ripandelli G; Parravano M; Varano M; Nardi M; Bocci G
    Pharmacogenomics; 2016; 17(1):35-9. PubMed ID: 26653034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Liu K; Chen LJ; Lai TY; Tam PO; Ho M; Chiang SW; Liu DT; Young AL; Yang Z; Pang CP
    Ophthalmology; 2014 Apr; 121(4):911-6. PubMed ID: 24393350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration.
    Sharma NK; Gupta A; Prabhakar S; Singh R; Sharma S; Anand A
    Curr Neurovasc Res; 2012 Nov; 9(4):256-65. PubMed ID: 23030506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
    Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.
    Molinaro A; Orlandi P; Niccolai F; Agretti P; De Marco G; Ferrarini E; Di Cosmo C; Vitti P; Piaggi P; Di Desidero T; Bocci G; Tonacchera M
    J Endocrinol Invest; 2020 Feb; 43(2):149-155. PubMed ID: 31376092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
    Oszajca K; Szemraj M; Szemraj J; Jurowski P
    Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
    García M; Álvarez L; Nogacka AM; González-Iglesias H; Escribano J; Fernández-Vega B; Fernández-Vega Á; Fernández-Vega L; Coca-Prados M
    Acta Ophthalmol; 2015 Dec; 93(8):e658-66. PubMed ID: 26152901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?
    Okur V; Cetin O; Cetin E; Tepeli E; Bulgu Y; Yildirim C
    Clin Exp Ophthalmol; 2015; 43(1):47-53. PubMed ID: 24995509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
    Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic variant rs4073 A→T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration.
    Hautamäki A; Seitsonen S; Holopainen JM; Moilanen JA; Kivioja J; Onkamo P; Järvelä I; Immonen I
    Acta Ophthalmol; 2015 Dec; 93(8):726-33. PubMed ID: 26154559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
    Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
    Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
    Wang VM; Rosen RB; Meyerle CB; Kurup SK; Ardeljan D; Agron E; Tai K; Pomykala M; Chew EY; Chan CC; Tuo J
    Mol Vis; 2012; 18():2578-85. PubMed ID: 23112570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
    McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF
    Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association and interaction effect between VEGF receptor-2 (VEGFR-2) gene polymorphisms and dietary pattern on blood uric acid in Malays and Indians.
    Roseline YW; Shidoji Y; Hon WM; Masaki M
    Malays J Nutr; 2012 Dec; 18(3):307-17. PubMed ID: 24568071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.